NYSCF – Robertson Investigator Makes Advances in Multiple Sclerosis Research
NYSCF – Robertson Stem Cell Investigator Dr. Paul Tesar, Case Western Reserve School of Medicine, and a team of scientists discovered that two drugs, one used...
70 Results
Clear Filters
NYSCF Scientists One Step Closer to Cell Replacement Therapies for MS
For the first time, NYSCF scientists generated induced pluripotent stem (iPS) cells lines from skin samples of patients with primary progressive multiple sclerosis and further, they...
Dr. Marius Wernig Awarded 4th Annual NYSCF – Robertson Stem Cell Prize
NYSCF announced that Dr. Marius Wernig, of Stanford University, is the recipient of the NYSCF – Robertson Stem Cell Prize. Dr. Wernig and his team discovered...
NYSCF Multiple Sclerosis Research Featured in Neurology Today
Neurology Today featured NYSCF – Helmsley Investigator Dr. Valentina Fossati’s latest research on multiple sclerosis in a larger story about Dr. Fossati and her personal commitment...
NYSCF Travels Out East to Discuss Latest Research
In conjunction with the Alzheimer’s Disease Resource Center (ADRC), NYSCF presented their latest Alzheimer’s research at the Jewish Center of the Hamptons in East Hampton. Presentations...
NYSCF Announces 2014 Class of NYSCF – Druckenmiller Fellows
NYSCF welcomed the 2014 class of NYSCF – Druckenmiller Postdoctoral Fellows at a reception at the Asia Society. These seven exceptional scientists work in stem cell...
First Disease-Specific Stem Cell Line by SCNT
A team of scientists led by the NYSCF Research Institute’s Dr. Dieter Egli report the first ever patient-specific, diploid (i.e. with two sets of chromosomes, the...
Scientists Upend 160 Years of Neuroanatomy With New Finding
NYSCF – Robertson Stem Cell Investigator Dr. Paola Arlotta, of Harvard University, has made an exciting breakthough and paradigm shift in the basic understanding of neuroanatomy....
Stem Cell Therapy Treatment for Multiple Sclerosis Approved by FDA for Stage I Clinical Trial
In an exciting new development, the Food and Drug Administration (FDA) has approved a new stem cell-derived treatment for a phase I clinical trial in the...
Shining a Light on MS: NYSCF Investigator Profiled
Multiple Sclerosis Discovery Forum followed NYSCF — Helmsley Investigator Valentina Fossati, PhD, on her quest that is as scientific as personal. When she turned 30, Fossati was diagnosed...
NYSCF Investigators Generate New Cells to Study Multiple Sclerosis: A Conversation with Paul Tesar and Marius Wernig
At our annual Innovator's retreat, our 2010 NYSCF — Robertson Stem Cell Investigators Paul Tesar, PhD, of Case Western University, and Marius Wernig, MD, PhD, of...
Skin Cells Transformed to Repair Multiple Sclerosis Damage
Multiple sclerosis, an autoimmune disease in which immune cells attack the fatty protective layer of myelin cells, may have a potential treatment. Through stem cell techniques,...
Dr. Fossati’s Work Opens a Window into MS
Dr. Valentina Fossati conducts research in The New York Stem Cell Foundation Laboratory to unlock the mysteries of multiple sclerosis (MS), a disease that affects...
Winter Research Update
Four NYSCF-supported researchers published exciting new research in major scientific journals this fall. In the November 6th issue of Nature, Jae-won Shim, PhD, a NYSCF –...
Multiple Sclerosis Research Center of New York Announces Clinical Trial for Multiple Sclerosis
11/21/11 The Multiple Sclerosis Research Center of New York (MSRCNY) and the International Cellular Medicine Society (ICMS) jointly announced today the ICMS Institutional Review Board’s (IRB)...
Susan L. Solomon to Speak on ‘State of Industry’ of Regenerative Medicine at Biotech Showcase in San Francisco
Susan L. Solomon to Speak on ‘State of Industry’ of Regenerative Medicine at Biotech Showcase in San Francisco NEW YORK, NY (January 9, 2012) – Susan L....
NYSCF – Robertson Investigator Paul Tesar Creates Cells That Die in Multiple Sclerosis
NYSCF – Robertson Investigator, Dr. Paul Tesar of Case Western Reserve University, published in Nature Methods today that they have succesfully produced the myelinating cells that...
Dr. Paul Tesar on Becoming a Scientist, his Research Goals, and his Newly Published Work
For the second in our series of researcher interviews, we bring you some thoughts from Dr. Paul Tesar, a member of the inaugural class of NYSCF...
Stem cell transplants show promise for MS: study
Reuters “CHICAGO (Reuters) – U.S. researchers have reversed multiple sclerosis symptoms in early stage patients by using bone marrow stem cell transplants to reset the immune...
NYSCF Responds to New Jersey Stem Cell Vote
The New York Stem Cell Foundation expresses its disappointment in the state of New Jersey for voting “no” on the Stem Cell Research Bond Act ballot...